Roger Zhang

Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies.

Spyglass Pharma provides medicine for ophthalmic diseases.

Raised $109,782,347.00 from RA Capital Management, Vertex Ventures HC, New Enterprise Associates, Samsara BioCapital and Vensana Capital.

Respiras high efficiency AOS Dry Powder Inhaler (DPI) technologies deliver dry powder drug products to the lung more effectively.

Raised $5,100,000.00 from Keiretsu Forum Northwest.

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Raised $266,000,000.00 from J.P. Morgan Asset Management, KB Investment, Japan Post Investment, Samsara BioCapital, TCG Crossover, DaVita Venture Group, Marshall Wace and Catalys Pacific.

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Raised $278,000,000.00 from Venrock Healthcare Capital Partners, OrbiMed, Samsara BioCapital, TCG Crossover and RA Capital Management.

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Raised $310,000,000.00 from Woodline Partners, Ally Bridge Group, Saturn V Capital, Novo Holdings, Perceptive Advisors, T. Rowe Price, Wellington Management, Third Rock Ventures, Opaleye Management and Samsara BioCapital.

Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on